Company: LIDRW
Filing Date: 2025-08-11
Form Type: S-3
Source: 0000947871-25-000731
Chunk: 30

Company: AEye, Inc.
Filing Date: 2025-08-11
Form: S-3
Chunk 30
---
 and deliver these shares to close out their short positions, or loan or pledge
the shares to broker-dealers that in turn may sell these shares. The Selling Stockholder may also enter into option or other transactions
with broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer
or other financial institution of shares of Common Stock covered by this prospectus, which shares such broker-dealer or other financial
institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction). We have advised the Selling
Stockholder that it is required to comply with Regulation M promulgated under the Exchange Act. With certain exceptions, Regulation M
precludes the Selling Stockholder, any affiliated purchasers, and any broker-dealer or other person who participates in the distribution
from bidding for or purchasing, or attempting to induce any person to bid for or purchase any security which is the subject of the distribution
until the entire distribution is complete. Regulation M also prohibits any bids or purchases made in order to stabilize the price of a
security in connection with the distribution of that security. All of the foregoing may affect the marketability of the securities offered
by this prospectus.

We have agreed to use our reasonable best efforts
to keep the registration statement, of which this prospectus forms a part, effective and supplemented to ensure that it remains available
for the resale of all shares issuable upon exercise of the Warrant. Our obligation to maintain the effectiveness of the registration statement
will continue until the earliest of (a) the date on which all such shares have been sold, transferred, disposed of or exchanged in accordance
with the registration statement, (b) the date on which all such shares may be sold publicly without restriction or limitation under Rule
144 and without the requirement to be in compliance with Rule 144(c)(1) under the Securities Act or (c) the date on which the shares or
the right to acquire such shares have ceased to be outstanding under the Warrant.

| 21 |

<div align='center'>LEGAL MATTERS</div>

The validity of the shares of Common Stock offered
hereby will be passed upon for us by Allen Overy Shearman Sterling US LLP, Menlo Park, California.

<div align='center'>EXPERTS</div>

The financial statements of AEye, Inc. as of
December 31, 2023, and 2022, and for each of the two years in the period ended